Chimerix Inc (STU:CXF)
€ 3.03 0.21 (7.45%) Market Cap: 298.58 Mil Enterprise Value: 168.48 Mil PE Ratio: 0 PB Ratio: 2.29 GF Score: 51/100

Chimerix Inc at Jefferies Healthcare Conference (Virtual) Transcript

Jun 01, 2021 / 02:00PM GMT
Release Date Price: €6.27 (+0.72%)
Maury Raycroft
Jefferies,LLC - Analyst

Hi, my name is Maury Raycroft and I am one of the biotech analysts at Jefferies. It's with great pleasure that I'd like to welcome Mike Sherman, the CEO of Chimerix. Chimerix is an interesting company with three late-stage programs, each unique.

And without further ado, I'll turn it over to Mike to tell you more about Chimerix. And for the audience, if you have questions, feel free to submit them online, and I will try to get to some of those at the end. Thanks for joining us today, Mike.

Mike Sherman
Chimerix Inc - CEO

Thanks, Maury. Really appreciate you having us. As you mentioned, we have got some exciting programs. And this year, in particular, a number of those set to hit some milestones, so look forward to giving you an update here. I will make some forward-looking statements, so please refer to our most recent SEC filings for a more complete disclosure of those risks and uncertainties.

As Maury mentioned, we've got a bit of a unique program here. And as I joined the Company a couple of years

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot